Multiple Sclerosis – Cladribine tablets (Mavenclad)

23rd January 2018 by Louise Hudman

Multiple Sclerosis – Cladribine tablets (Mavenclad)

This is a new guideline from NICE on a new treatment for MS. Obviously we won’t be prescribing this, but I thought it worth mentioning as we may see patients starting to use it.

It is an oral medication, given as short courses (eg for 2 years, it is given for just a few days in each of a couple of months). This compares to other medications, which are either daily and continuous, or injections, or IV medications given in hospital.

It will be used as a second line treatment in relapsing-remitting MS, or in rapidly evolving severe relapsing-remitting MS.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


"As a newly-qualified CCT and a GP moving to a new region post-CCT, I found LocumDeck and the NASGP to be very helpful. LocumDeck has been useful: Ali Lewis helped me to set myself up, get in touch with practices and book sessions, and also helped me chase payments. The NASGP itself, providing peer support and advice, has also been very good. I would certainly encourage my colleagues to join."

Dr Smita Sharma, GP, Hertfordshire

See the full list of features within our NASGP membership plans